高危前列腺癌症患者的最佳治疗

Q4 Medicine

Libri Oncologici Pub Date : 2019-01-29 DOI:10.20471/lo.2018.46.02-03.15

Katarina Antunac

{"title":"高危前列腺癌症患者的最佳治疗","authors":"Katarina Antunac","doi":"10.20471/lo.2018.46.02-03.15","DOIUrl":null,"url":null,"abstract":"Treatment options in subset of patients with high-risk prostate cancer are various: radical prostatectomy, hormonal therapy, radiation therapy, combined modality approach, addition of chemotherapy. Based on randomised trials data, optimal approach would consist of radical radiotherapy and long term hormonal therapy. If technically possible high dose radiotherapy, hypofractionation, image guided radiotherapy, simultaneous integrated boost on dominant intraprostatic lesion and HDR brachytherapy boost should be used as well.","PeriodicalId":53700,"journal":{"name":"Libri Oncologici","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimal treatment of patients with high-risk prostate cancer\",\"authors\":\"Katarina Antunac\",\"doi\":\"10.20471/lo.2018.46.02-03.15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Treatment options in subset of patients with high-risk prostate cancer are various: radical prostatectomy, hormonal therapy, radiation therapy, combined modality approach, addition of chemotherapy. Based on randomised trials data, optimal approach would consist of radical radiotherapy and long term hormonal therapy. If technically possible high dose radiotherapy, hypofractionation, image guided radiotherapy, simultaneous integrated boost on dominant intraprostatic lesion and HDR brachytherapy boost should be used as well.\",\"PeriodicalId\":53700,\"journal\":{\"name\":\"Libri Oncologici\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Libri Oncologici\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20471/lo.2018.46.02-03.15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Libri Oncologici","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20471/lo.2018.46.02-03.15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

高危前列腺癌症患者亚群的治疗方案多种多样：根治性前列腺切除术、激素治疗、放射治疗、联合治疗和化疗。根据随机试验数据，最佳方法包括根治性放疗和长期激素治疗。如果技术上可行，还应使用高剂量放射治疗、低分割、图像引导放射治疗、同时对主要瓣内病变进行综合增强和HDR近距离放射治疗增强。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Optimal treatment of patients with high-risk prostate cancer

Treatment options in subset of patients with high-risk prostate cancer are various: radical prostatectomy, hormonal therapy, radiation therapy, combined modality approach, addition of chemotherapy. Based on randomised trials data, optimal approach would consist of radical radiotherapy and long term hormonal therapy. If technically possible high dose radiotherapy, hypofractionation, image guided radiotherapy, simultaneous integrated boost on dominant intraprostatic lesion and HDR brachytherapy boost should be used as well.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Libri Oncologici Medicine-Oncology

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： - Genitourinary cancer: the potential role of imaging - Hemoglobin level and neoadjuvant chemoradiation in patients with locally advanced cervical carcinoma